Cargando…
Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645553/ http://dx.doi.org/10.1186/2051-1426-3-S2-P129 |
| _version_ | 1782400838653706240 |
|---|---|
| author | Chandar, Ashwin Silk, Ann W Clark, Joseph I Daniels, Gregory A McDermott, David F Morse, Michael Wong, Michael KK Stein, Mark Mehnert, Janice Danish, Shabbar Aung, Sandra Kaufman, Howard L |
| author_facet | Chandar, Ashwin Silk, Ann W Clark, Joseph I Daniels, Gregory A McDermott, David F Morse, Michael Wong, Michael KK Stein, Mark Mehnert, Janice Danish, Shabbar Aung, Sandra Kaufman, Howard L |
| author_sort | Chandar, Ashwin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645553 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46455532015-11-20 Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma Chandar, Ashwin Silk, Ann W Clark, Joseph I Daniels, Gregory A McDermott, David F Morse, Michael Wong, Michael KK Stein, Mark Mehnert, Janice Danish, Shabbar Aung, Sandra Kaufman, Howard L J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645553/ http://dx.doi.org/10.1186/2051-1426-3-S2-P129 Text en Copyright © 2015 Chandar et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Chandar, Ashwin Silk, Ann W Clark, Joseph I Daniels, Gregory A McDermott, David F Morse, Michael Wong, Michael KK Stein, Mark Mehnert, Janice Danish, Shabbar Aung, Sandra Kaufman, Howard L Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma |
| title | Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma |
| title_full | Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma |
| title_fullStr | Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma |
| title_full_unstemmed | Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma |
| title_short | Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma |
| title_sort | efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645553/ http://dx.doi.org/10.1186/2051-1426-3-S2-P129 |
| work_keys_str_mv | AT chandarashwin efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma AT silkannw efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma AT clarkjosephi efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma AT danielsgregorya efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma AT mcdermottdavidf efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma AT morsemichael efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma AT wongmichaelkk efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma AT steinmark efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma AT mehnertjanice efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma AT danishshabbar efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma AT aungsandra efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma AT kaufmanhowardl efficacyandsafetyofhighdoseinterleukin2treatmentinpatientswithahistoryofbrainmetastasesfromrenalcellcarcinoma |